PHARMACYTE BIOTECH, INC. Increase (Decrease) in Accounts Receivable
PHARMACYTE BIOTECH, INC. (PMCB) reported Increase (Decrease) in Accounts Receivable of $0 for the 12-month period ending 2015-04-30, per its 10-K/A filed 2016-01-19.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2016-01-19
- PHARMACYTE BIOTECH, INC. increase (decrease) in accounts receivable for the quarter ending 2014-04-30 was $0.00.
- PHARMACYTE BIOTECH, INC. increase (decrease) in accounts receivable for the quarter ending 2014-01-31 was $0.00.
- PHARMACYTE BIOTECH, INC. increase (decrease) in accounts receivable for the quarter ending 2013-10-31 was $0.00.
- PHARMACYTE BIOTECH, INC. increase (decrease) in accounts receivable for the quarter ending 2013-07-31 was $0.00.
- PHARMACYTE BIOTECH, INC. increase (decrease) in accounts receivable for fiscal 2015 was $0.00.
- PHARMACYTE BIOTECH, INC. increase (decrease) in accounts receivable for fiscal 2014 was $0.00.
- PHARMACYTE BIOTECH, INC. increase (decrease) in accounts receivable for fiscal 2013 was -$2.58K, a 138.17% decline from fiscal 2012.
- PHARMACYTE BIOTECH, INC. increase (decrease) in accounts receivable for fiscal 2012 was $6.76K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2015-04-30 | $0.00 10-K/A · filed 2016-01-19 | |||||||
| 2014-04-30 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-01-19 | $0.00 derived: sum of 2 quarters · filed 2016-01-19 | $0.00 derived: sum of 3 quarters · filed 2016-01-19 | $0.00 10-K/A · filed 2016-01-19 | ||||
| 2014-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-17 | $0.00 derived: sum of 2 quarters · filed 2014-03-17 | $0.00 10-Q · filed 2014-03-17 | $0.00 derived: sum of 4 quarters · filed 2016-01-19 | ||||
| 2013-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-12-16 | $0.00 10-Q · filed 2013-12-16 | $0.00 derived: sum of 3 quarters · filed 2016-01-19 | $0.00 derived: sum of 4 quarters · filed 2016-01-19 | ||||
| 2013-07-31 | $0.00 10-Q · filed 2013-09-16 | $0.00 derived: sum of 2 quarters · filed 2016-01-19 | $0.00 derived: sum of 3 quarters · filed 2016-01-19 | $0.00 derived: sum of 4 quarters · filed 2016-01-19 | ||||
| 2013-04-30 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-01-19 | $0.00 derived: sum of 2 quarters · filed 2016-01-19 | $0.00 derived: sum of 3 quarters · filed 2016-01-19 | -$2.58K 10-K/A · filed 2016-01-19 | ||||
| 2013-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-17 | $0.00 derived: sum of 2 quarters · filed 2014-03-17 | -$2.58K 10-Q · filed 2014-03-17 | -$13.08K derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2012-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-12-16 | -$2.58K 10-Q · filed 2013-12-16 | -$13.08K derived: sum of 3 quarters · filed 2013-12-16 | -$2.46K derived: sum of 4 quarters · filed 2013-12-16 | ||||
| 2012-07-31 | -$2.58K 10-Q · filed 2013-09-16 | $2.58K 10-Q · filed 2012-09-19 | -$13.08K derived: sum of 2 quarters · filed 2013-09-16 | -$2.46K derived: sum of 3 quarters · filed 2013-09-16 | $10.47K derived: sum of 4 quarters · filed 2013-09-16 | |||
| 2012-04-30 | -$10.50K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-29 | $116.00 derived: sum of 2 quarters · filed 2013-07-29 | $13.05K derived: sum of 3 quarters · filed 2013-07-29 | $6.76K 10-K · filed 2013-07-29 | -$6.76K 10-K · filed 2012-08-14 | |||
| 2012-01-31 | $10.62K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-26 | $23.55K derived: sum of 2 quarters · filed 2013-03-26 | $17.26K 10-Q · filed 2013-03-26 | -$17.26K 10-Q · filed 2012-03-21 | $36.24K derived: sum of 4 quarters · filed 2013-03-26 | |||
| 2011-10-31 | $12.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-26 | $6.65K 10-Q · filed 2012-12-26 | -$6.65K 10-Q · filed 2011-12-15 | $25.62K derived: sum of 3 quarters · filed 2012-12-26 | $8.30K derived: sum of 4 quarters · filed 2012-12-26 | |||
| 2011-07-31 | -$6.29K 10-Q · filed 2012-09-19 | $12.69K derived: sum of 2 quarters · filed 2012-09-19 | -$4.63K derived: sum of 3 quarters · filed 2012-09-19 | -$13.31K derived: sum of 4 quarters · filed 2012-09-19 | ||||
| 2011-04-30 | $18.98K derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-14 | $1.66K derived: sum of 2 quarters · filed 2012-08-14 | -$7.02K derived: sum of 3 quarters · filed 2012-08-14 | -$931.00 10-K · filed 2012-08-14 | ||||
| 2011-01-31 | -$17.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-21 | -$25.99K derived: sum of 2 quarters · filed 2012-03-21 | -$19.91K 10-Q · filed 2012-03-21 | |||||
| 2010-10-31 | -$8.68K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2011-12-15 | -$2.59K 10-Q · filed 2011-12-15 | ||||||
| 2010-07-31 | $6.09K 10-Q/A · filed 2011-09-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |